Detalhe da pesquisa
1.
Targeting hyperactive platelet-derived growth factor receptor-ß signaling in T-cell acute lymphoblastic leukemia and lymphoma.
Haematologica
; 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37941480
2.
Targeting cytokine- and therapy-induced PIM1 activation in preclinical models of T-cell acute lymphoblastic leukemia and lymphoma.
Blood
; 135(19): 1685-1695, 2020 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32315407
3.
Direct and indirect anti-leukemic properties of activity-on-target interferons for the treatment of T-cell acute lymphoblastic leukemia.
Haematologica
; 107(6): 1448-1453, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647441
4.
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphoma.
Haematologica
; 104(1): e17-e20, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076176
5.
Pre-Clinical Evaluation of the Hypomethylating Agent Decitabine for the Treatment of T-Cell Lymphoblastic Lymphoma.
Cancers (Basel)
; 15(3)2023 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765607
6.
Targeting steroid resistance in T-cell acute lymphoblastic leukemia.
Blood Rev
; 38: 100591, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31353059